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Background: Pneumonia is the single largest killer of children
under-ﬁve worldwide. The disease takes the lives of over 2 million
children under the age of ﬁve every year - nearly one fourth of these
deaths occur in India alone. About half of pneumonia cases in India
are caused by bacteria and could be treated with antibiotics.
Methods & Materials: This open-label two-arm randomized
clinical trial was conducted to determine the differences in failure
of treatment with a 7-day course of oral amoxicillin administered
for ﬁrst 48hours in the hospital followed by 5 days at home in com-
parison to being administered at home for all 7 days, in children 3
to 59months oldwhohaveWHOdeﬁned severe pneumonia. Respi-
ratory syncytial virus (RSV) antigen in nasal washings using ELISA
method, and standardmicrobiological techniques to isolate S. pneu-
moniae andH. inﬂuenzae frombaseline nasopharyngeal swabswere
carried out.
Results: A total of 377 children were included. The samples
obtained from the enrolled patients revealed that 36.87% had S.
pneumoniae, 16.44% had H. inﬂuenza, and 53.31% had RSV colo-
nization. There were no signiﬁcant differences in rates of isolation
between thehomeand thehospital group (p=0.53). The ratesof iso-
lation of these organisms were not predictive of treatment failure
with oral amoxicillin.
Conclusion: S. pneumoniae is the most common bacterial cause
of severe pneumonia in children under-ﬁve in India. Oral amoxi-
cillin given in the home setting is as good when given in hospital
setting.
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Incidence and severity of childhood pneumonia
in the Drakenstein Child Lung Health Study, a
birth cohort in South Africa
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Background: Childhood pneumonia remains the major cause
of global under-5 mortality. Conjugate vaccinations against Strep-
tococcus pneumoniae (PCV13)was introduced into the SouthAfrican
primary health care program in 2009, while immunisation against
Haemophilus inﬂuenzae b has been in place for a decade. This study
investigated the incidence and severity of pneumonia in a South
African birth cohort with high coverage for these vaccines.
Methods & Materials: Active pneumonia case detection was
performed from June 2012 to November 2013, in infants enrolled
in the Drakenstein Child Lung Health study, a birth cohort study
in a peri-urban area of South Africa. Pneumonia case deﬁnitions
and treatment were according to IMCI and national guidelines;
ambulatory and hospitalised cases were included.
Results: Amongst 555 births, 369 child-years of follow-up were
accrued with median follow-up of 33 weeks (IQR 19 – 49 weeks).
108 pneumonia episodes occurred in 87 children, an incidence of
0.29 episodes per child-year (e/cy), 95%CI 0.24 – 0.35. First pneu-
monia events occurred before 14-week vaccination in 45 children
(42%); the earliest event occurred at 21 days. There were 43 cases
of hospitalised pneumonia, (incidence 0.12 e/cy, 95% CI 0.08 –
0.16) and 65 ambulatory episodes (incidence 0.18 e/cy, 95%CI 0.14
– 0.22). Hospitalised cases were younger than ambulatory cases:
median age 13 weeks (IQR 6 – 27), vs 21 weeks, (IQR 12 – 24),
p=0.03.Median lengthof hospitalisationwas3days, (IQR2 -5days).
The in-hospital case fatality was 5%; there were no deaths amongst
ambulatory cases andno caseprogressed to require hospitalisation.
Conclusion: There was a high incidence of pneumonia and of
severe disease despite high PCV coverage in this area
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